Treatment outcomes of Anti-angiogenic agent (Bevacizumab) in Glioblastoma patients: A rapid review
Treatment outcomes of Anti-angiogenic agent (Bevacizumab) in Glioblastoma patients: A rapid review Introduction: Glioblastomas constitute some of the most aggressive brain tumors known. They exhibit high mortality rates, and low survival rates. Additionally, owing to its location, it results in a range of neurologic, functional, and physical dysfunction within a relatively short period. Despite the […]